Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1960 1
1961 2
1963 2
1964 1
1967 1
1970 1
1971 1
1973 1
1984 1
1985 1
1988 3
1992 1
1993 1
1994 7
1995 2
1996 4
1997 1
1998 1
1999 4
2000 2
2001 2
2004 5
2005 2
2006 5
2007 2
2008 2
2009 3
2010 1
2011 3
2012 1
2014 3
2015 1
2016 5
2017 6
2018 4
2019 2
2020 9
2021 4
2022 4
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity.
Zheng Q, Tang J, Aicher A, Bou Kheir T, Sabanovic B, Ananthanarayanan P, Reina C, Chen M, Gu JM, He B, Alcala S, Behrens D, Lawlo RT, Scarpa A, Hidalgo M, Sainz B Jr, Sancho P, Heeschen C. Zheng Q, et al. Among authors: behrens d. J Exp Clin Cancer Res. 2023 Nov 28;42(1):323. doi: 10.1186/s13046-023-02883-y. J Exp Clin Cancer Res. 2023. PMID: 38012687 Free PMC article.
Pancreatic cancer models for translational research.
Behrens D, Walther W, Fichtner I. Behrens D, et al. Pharmacol Ther. 2017 May;173:146-158. doi: 10.1016/j.pharmthera.2017.02.013. Epub 2017 Feb 4. Pharmacol Ther. 2017. PMID: 28174092 Review. No abstract available.
Predictive In Vivo Models for Oncology.
Behrens D, Rolff J, Hoffmann J. Behrens D, et al. Handb Exp Pharmacol. 2016;232:203-21. doi: 10.1007/164_2015_29. Handb Exp Pharmacol. 2016. PMID: 26489829 Review.
Iatrogenic lymphoproliferative disorder.
Nader K, Behrens DS, Leon CA, Schwarting R, Ferber A. Nader K, et al. Among authors: behrens ds. Am J Hematol. 2014 Jul;89(7):787-8. doi: 10.1002/ajh.23739. Am J Hematol. 2014. PMID: 24729413 Free article. No abstract available.
Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylation.
Godfrey LK, Forster J, Liffers ST, Schröder C, Köster J, Henschel L, Ludwig KU, Lähnemann D, Trajkovic-Arsic M, Behrens D, Scarpa A, Lawlor RT, Witzke KE, Sitek B, Johnsen SA, Rahmann S, Horsthemke B, Zeschnigk M, Siveke JT. Godfrey LK, et al. Among authors: behrens d. Clin Epigenetics. 2024 Jan 16;16(1):13. doi: 10.1186/s13148-024-01623-z. Clin Epigenetics. 2024. PMID: 38229153 Free PMC article.
Animal models for personalized treatment options.
Fichtner I, Klinghammer K, Behrens D, Flechsig S, Rolff J, Becker M, Wulf-Goldenberg A, Stecklum M, Rivera M, Brzezicha B, Jandrig B, Hoffmann J. Fichtner I, et al. Among authors: behrens d. Int J Clin Pharmacol Ther. 2017 Aug;55(8):698-700. doi: 10.5414/CPXCES15EA09. Int J Clin Pharmacol Ther. 2017. PMID: 28696202 No abstract available.
Understanding the Impact of Social Networks on the Spread of Obesity.
Tuson M, Harper P, Gartner D, Behrens D. Tuson M, et al. Among authors: behrens d. Int J Environ Res Public Health. 2023 Jul 26;20(15):6451. doi: 10.3390/ijerph20156451. Int J Environ Res Public Health. 2023. PMID: 37568992 Free PMC article.
110 results